Advice and Guidance FAQs
RAG rating
Document type
Primary Care prescribing resource
Hertfordshire and West Essex ICB
Output type
Pharmacy / Prescribing

Eclipse Live

Eclipse Advice and Guidance - Q & A

May 2023

Q1 What is Eclipse used for?

A: Eclipse is a medication-based risk stratification tool designed to help pick up patients who are likely to be put at risk of harm from their medication.

Q2 Does Eclipse work?

A: The use of Eclipse is associated with significant reductions in emergency admissions and A&E attendances from primary care. In 2015, Eclipse carried out a service impact assessment on eight million patients and found that 10% reduction in A&E admissions were identified.

Q3 Is Eclipse an accredited/secure system?

A: Yes, NHS Pathways is accessed through the secure Advice & Guidance (Eclipse Live) portal. In addition to being hosted on a secure ISO27001 server, two-factor authentication is required to log in. This simply involves entering an access code that is sent by SMS to your mobile or emailed to your NHS email address.

GP data is extracted and patient identifiable data is retrievable only at practice level.

It has also gone through NHS Digital and has been validated and funded for GP practices across Herts and West Essex ICB and is currently utilised in 2738 surgeries across the UK as of April 2023.

Q4 Why are we implementing Eclipse across the ICB?

A: The system has been in place in West Essex and South West Herts for a number of years and has been embedded into routine practice in the majority of GP practices. Practices managing alerts highlighted by the system report that they support them to improve medicines related systems and processes to ensure safer prescribing for their patients. Active alert monitoring supports CQC inspections.

Q5 What is the evidence behind the alert?

A: Each RADAR 500 alert will have a link to where the evidence behind this is based. This is underpinned by national guidance and safety alerts e.g., MHRA, NICE, CQC, BNF and SPS Drug Monitoring in Adults in Primary Care.

For examples of radar alerts please see: RADAR 500 user guide

Q6 How many red alerts are expected to be seen?

A: Eclipse refreshes all Radar500 alerts on a Sunday, based on the latest automated data extraction. On average the red alerts are normally 1 per 1000 patients per GP practice. Reflecting good practice, practices should review red alerts at the beginning of the week and over time the number of red alerts that need addressing will reduce.

Q7 What do GP practice staff need to do?

A: To support safer prescribing, the HWE ICB GP Enhanced Care Framework for 23/24 requires GP practices to review all red RADAR alerts that are reported on a weekly basis. Practices should develop systems to address or review these alerts and ‘click’ the appropriate button in the Eclipse Live system to reflect that this has been done. Clinical documentation of the management of alerts should also be recorded in the patient’s clinical system.

Q8 Who needs to be reviewing these alerts?

A: The alerts can be reviewed by either a GP, Nurse or Pharmacist/Pharmacy technician. GP practices may also put in place processes for non-clinical staff to forward the alerts to the appropriate clinician for review. If this process is applied practice staff should ensure that there is a plan to update the Eclipse system to show that alerts have been reviewed/addressed.

Q9 How do I set up additional users on Eclipse once my practice is live on the system?

A: Additional user requests need to be sent through by either the Practice Manager/Lead GP or named primary user in the GP practice. These need to be emailed to They will need to include Name, Job Title, NHS Email and Name of the practice.

Q10 Forgetting or resetting log in details.

A: Email or reset via Eclipse homepage.

Version number
Developed by
Niraj Shah, Pharmaceutical Advisor, HWE ICB; Janet Weir, Lead Pharmacist, HWE ICB
Approved by
Date approved / updated
May 2023
Review date
The recommendation is based upon the evidence available at the time of publication. This recommendation will be reviewed upon request in the light of new evidence becoming available.
Superseded version